Pharming Group announces the 2024 Annual General Meeting of Shareholders
Leiden, The Netherlands, April 4, 2024: Pharming Group N.V. (“Pharming” or “the Company”) (Euronext Amsterdam: PHARM / Nasdaq: PHAR) announces […]
Amaroq announces First Underground Mining Blast at Nalunaq
TORONTO, ONTARIO, April 04, 2024 (GLOBE NEWSWIRE) — (“Amaroq Minerals” or the “Company”) Amaroq announces First Underground Mining Blast at […]
Pharming Group announces the filing of its 2023 Annual Report and Form 20-F
Leiden, The Netherlands, April 4, 2024: Pharming Group N.V. (“Pharming” or “the Company”) (Euronext Amsterdam: PHARM / Nasdaq: PHAR) announces […]
Christina Lake Cannabis Announces Delay in Filing its 2023 Annual Financial Statements
VANCOUVER, British Columbia, April 03, 2024 (GLOBE NEWSWIRE) — Christina Lake Cannabis Corp. (“CLC” or the “Company“) (CSE: CLC) announced […]
Volaris Reports March 2024 Traffic Results: 87% Load Factor
MEXICO CITY, April 03, 2024 (GLOBE NEWSWIRE) — Controladora Vuela Compañía de Aviación, S.A.B. de C.V. (NYSE: VLRS and BMV: […]
TSX News -
PyroGenesis Announces the Appointment of Paul Rajchgod to the Board of Directors
MONTREAL, April 03, 2024 (GLOBE NEWSWIRE) — PyroGenesis Canada Inc. (http://pyrogenesis.com) (TSX: PYR) (OTCQX: PYRGF) (FRA: 8PY), a high-tech company […]
Enhanced Capital Group Named to 13th Annual ImpactAssets 50 List
DALLAS, April 03, 2024 (GLOBE NEWSWIRE) — P10, Inc. (NYSE: PX), a leading private markets solutions provider, today announced that its […]
Opthea Appoints Sujal Shah to the Board of Directors
MELBOURNE, Australia and PRINCETON, N.J., April 03, 2024 (GLOBE NEWSWIRE) — Opthea Limited (ASX/NASDAQ: OPT “Opthea”, the “Company”), a clinical-stage […]
Comstock Publishes its 1Q24 Stakeholder Perception Analysis Report
VIRGINIA CITY, Nev., April 03, 2024 (GLOBE NEWSWIRE) — Comstock Inc. (NYSE: LODE) (“Comstock”) announces its Q1 2024 Stakeholder Perception […]
Palisade Bio Announces 1-for-15 Reverse Stock Split
Carlsbad, CA, April 03, 2024 (GLOBE NEWSWIRE) — Palisade Bio, Inc. (Nasdaq: PALI), (“Palisade”, “Palisade Bio” or the “Company”), a biopharmaceutical company […]
